AbCellera Biologics (ABCL) Property, Plant & Equipment (Net) (2020 - 2026)
Powered by 
Analysis
AbCellera Biologics (ABCL) Property, Plant & Equipment (Net) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Property, Plant & Equipment (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn | 1.67 Bn |
| 2 | Regeneron Pharmaceuticals | 85.51 Bn | 77.52 Bn | 3.93 Bn | 5.46 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | 1.96 Bn |
| 4 | Moderna | 58.20 Bn | 53.06 Bn | 52.00 Mn | 2.06 Bn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | 34.61 Mn |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | 1.64 Bn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 554.14 Mn |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - | - |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | 107.22 Mn |
| 10 | AbCellera Biologics | 3.47 Bn | 3.47 Bn | - | 416.68 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 416.68 Mn |
| Mar 31, 2026 | 422.81 Mn |
| Dec 31, 2025 | 428.00 Mn |
| Sep 30, 2025 | 427.36 Mn |
| Jun 30, 2025 | 424.02 Mn |
| Mar 31, 2025 | 347.10 Mn |
| Dec 31, 2024 | 340.43 Mn |
| Sep 30, 2024 | 331.26 Mn |
| Jun 30, 2024 | 318.88 Mn |
| Mar 31, 2024 | 306.08 Mn |
| Dec 31, 2023 | 287.70 Mn |
| Sep 30, 2023 | 277.21 Mn |
| Jun 30, 2023 | 259.64 Mn |
| Mar 31, 2023 | 233.19 Mn |
| Dec 31, 2022 | 217.26 Mn |
| Sep 30, 2022 | 200.60 Mn |
| Jun 30, 2022 | 149.18 Mn |
| Mar 31, 2022 | 122.05 Mn |
| Dec 31, 2021 | 111.62 Mn |
| Sep 30, 2021 | 91.58 Mn |